Could be an interesting couple of weeks. Sarah confirming a DSMB report in early August that will be press released based on jkj.

Also, the end of July marks the 3 month period from when grow asset talked to Don about Zenith and Don intimated that Zenith was essentially sold (we don’t know what was to be sold but the inference and expectation of something being sold and shareholders being rewarded was made by Don to GAC). If I receive a Zenith reward I’ll be putting it right into Resverlogix. That’s my plan because I believe in the science and that the stock is grossly undervalued. I believe that Don said to GAC at that discussion that….we’ve (RVX) been silent but not for long. Let's hope Don holds up to his word. Of course "before to long" has a different meaning in biotech.

Also, from science posters it does seem that scientific interest in the merits of BET inhibition is gaining momentum.

I hope Don comes through.

GLTA

Toinv